Form 4: KORU Medical Systems Director Donna French Increases Stake with Significant Stock Purchase

KORU Medical Systems Director Donna French has acquired 4,189 shares of common stock at $33.58 per share, increasing her direct beneficial ownership to 84,974 shares.

Summary

• Donna French, a Director of KORU Medical Systems, Inc. (KRMD), acquired 4,189 shares of the company's common stock.
• The transaction occurred on July 2, 2025, at a price of $33.58 per share.
• Following this acquisition, Ms. French directly beneficially owns a total of 84,974 shares of KORU Medical Systems common stock.
• The total value of the acquired shares is approximately $140,669.62 (4,189 shares multiplied by $33.58 per share).

Sentiment

Score: 8

Explanation: The acquisition of a significant number of shares by a director indicates strong internal confidence in the company's prospects, which is a highly positive signal for investors.

Positives

• A Director's acquisition of additional shares signals confidence in the company's future prospects and valuation.
• The increase in direct beneficial ownership by a key insider aligns the director's interests more closely with those of other shareholders.

Future Outlook

Not applicable. This Form 4 filing reports a completed transaction and does not provide forward-looking statements or guidance.

Industry Context

Insider buying, especially by a director, is generally interpreted by the market as a positive signal, indicating that those with intimate knowledge of the company believe its stock is undervalued or has strong future potential. This action aligns the director's financial interests more closely with shareholders.

Comparison to Industry Standards

• Insider buying is a common practice across industries, and a director increasing their stake is generally viewed as a strong vote of confidence.
• While specific comparable companies or projects are not detailed in a Form 4, the act of an insider purchasing shares is a widely recognized indicator of internal optimism, often outperforming general market sentiment in the short to medium term.

Related Party Transactions

• This filing itself is a disclosure of a related party transaction, specifically the acquisition of common stock by Donna French, a Director of KORU Medical Systems, Inc.

Stakeholder Impact

• Shareholders: Likely to view the director's share purchase positively, as it suggests management confidence and aligns interests.

Key Dates

Recommendation

Keywords

KORU Medical Systems, KRMD, Donna French, Director, Insider Trading, Stock Acquisition, Beneficial Ownership, SEC Form 4, Equity Purchase, Corporate Governance